Sy Chyi Yeoh looks at some of the practical considerations faced by Chinese firms looking to expand overseas.
Sy Chyi Yeoh
Advertisement
Sy Chyi Yeoh is Director of Business Development at regulatory and Pharmacovigilance service provider ELC Group, part of global life science consultancy PLG (Product Life Group).
Articles by Sy Chyi Yeoh
Advertisement
Latest Updated Articles
Harnessing China’s Global OpportunityPublished: August 26th 2021 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Johnson and Johnson Reveals Plan to Separate Orthopaedics Business
2
The Most-Favored-Nation Policy: Outlook and Implications Beyond U.S.
3
Nabla Bio Enters $1 Billion Multi-Year Research Collaboration with Takeda
4
The Evolving Landscape in Psychiatry: Challenges and Opportunities for Biopharma
5
